Amy McMurry, NP
Registered Nurse · Birmingham, ALNPI 1588208938
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 10.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $653 and has fallen 94.2% since, to $38 in 2025. Among registered nurse clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Redhill Biopharma Inc.$118
- GRT US Holding, Inc.$115
- Amgen$108
- Merck$79
- Biohaven Pharmaceutical Holding Company Ltd.$75
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$69
- plus $615 from 20 others
What the payments were for
- Food & beverage$1,179100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,179 in reported general payments places this provider in the 95th percentile of 103 registered nurse providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 33 | $509 |
| Methocarbamol | 35 | $397 |
| Tizanidine Hcl | 36 | $223 |
| Methylprednisolone | 26 | $162 |
Paid to pharmacies, not to this prescriber.
Other registered nurse in Birmingham
- Justin PerryBirmingham$4K
- Frances BosargeBirmingham$1K
- Theresa SchillerBirmingham$994
- Maria BedardBirmingham$595
- Caleb LightBirmingham$587
- Lauren CopelandBirmingham$560
- Stacey BessiereBirmingham$533
- Brittany PraterBirmingham$269
- Katherine ParkerBirmingham$220
- Anthony TortomaseBirmingham$182
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.